Patterson CompaniesPDCO
PDCO
About: Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.
Employees: 7,600
0
Funds holding %
of 7,419 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
69% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 45
59% more call options, than puts
Call options by funds: $27.9M | Put options by funds: $17.6M
43% more capital invested
Capital invested by funds: $1.62B [Q3] → $2.32B (+$700M) [Q4]
23% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 87
9% more funds holding
Funds holding: 278 [Q3] → 304 (+26) [Q4]
1.59% more ownership
Funds ownership: 83.99% [Q3] → 85.57% (+1.59%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for PDCO.
Financial journalist opinion
Neutral
Business Wire
2 weeks ago
Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (NASDAQ: PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson's President and Chief Executive Officer, said, “I would like to express my gratitude t.
Positive
Zacks Investment Research
3 weeks ago
Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?
Patterson Cos. (PDCO) reported earnings 30 days ago.
Negative
Zacks Investment Research
1 month ago
PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract
Patterson Companies' overall top-line figure for the third quarter of fiscal 2025 reflects weak segmental performance.
Negative
Zacks Investment Research
1 month ago
Patterson Cos. (PDCO) Q3 Earnings and Revenues Lag Estimates
Patterson Cos. (PDCO) came out with quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.62 per share.
Neutral
Business Wire
1 month ago
Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. “As we continue to progress toward closing our transaction with Patient Square Capital, our team remains focused on executing our strategy,” said Don Zurbay, President and CEO of Patterson Companies. “While our third quarter results were impacted by challenging market conditions, we remain confident in the long-term strength of Pat.
Neutral
Business Wire
1 month ago
PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth.
Neutral
Business Wire
2 months ago
Patterson Companies Announces Expiration of “Go-Shop” Period
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day “go-shop” period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. (“Patient Square”), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinanc.
Neutral
GlobeNewsWire
3 months ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Positive
Zacks Investment Research
4 months ago
PDCO Stock Gains on the News of Acquisition Deal With Patient Square
Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion.
Positive
Benzinga
4 months ago
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion.
Charts implemented using Lightweight Charts™